Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/050300external-prioritypatent/WO2014012007A2/en
Application filed by Oncomed Pharm IncfiledCriticalOncomed Pharm Inc
Publication of CR20150065ApublicationCriticalpatent/CR20150065A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente invención se relaciona con agentes de unión de RSPO, particularmente agentes de unión de RSPO y métodos de uso de agentes para tratar enfermedades tales como cáncer.The present invention relates to RSPO binding agents, particularly RSPO binding agents and methods of using agents to treat diseases such as cancer.
CR20150065A2012-07-132015-02-09
HUMAN R-SPONDIN PROTEIN UNION AGENTS (RSPO3) AND USES OF THE SAME
CR20150065A
(en)
Compounds derived from substituted pyrrole; preparation procedure; pharmaceutical composition that contains them; pharmaceutical combination; use to treat diseases such as cancers and immune system diseases.
Substituted bicyclic compounds; pharmaceutical composition that includes them; and use in the treatment of diseases such as cancer, Alzheimer's, AIDS, among others.